Ambev SA (NYSE:ABEV) shares hit a new 52-week high during trading on Tuesday . The stock traded as high as $6.73 and last traded at $6.69, with a volume of 21,024,288 shares changing hands. The stock had previously closed at $6.48.

Several research analysts have commented on the stock. Barclays PLC reissued a “hold” rating on shares of Ambev SA in a report on Sunday, July 30th. Credit Suisse Group raised shares of Ambev SA from a “neutral” rating to an “outperform” rating in a report on Tuesday. Finally, Zacks Investment Research raised shares of Ambev SA from a “sell” rating to a “hold” rating in a report on Thursday, June 15th. Three research analysts have rated the stock with a hold rating and four have given a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $6.10.

The stock has a market capitalization of $105.08 billion, a PE ratio of 27.88 and a beta of 0.66. The company’s 50-day moving average is $6.21 and its 200 day moving average is $5.81.

Ambev SA (NYSE:ABEV) last announced its quarterly earnings data on Thursday, July 27th. The company reported $0.04 earnings per share (EPS) for the quarter, hitting the Zacks’ consensus estimate of $0.04. The firm had revenue of $3.20 billion during the quarter, compared to analysts’ expectations of $3.33 billion. Ambev SA had a net margin of 27.14% and a return on equity of 23.24%. On average, analysts anticipate that Ambev SA will post $0.23 earnings per share for the current year.

Several hedge funds and other institutional investors have recently made changes to their positions in ABEV. Great West Life Assurance Co. Can purchased a new stake in shares of Ambev SA in the first quarter worth $427,000. Advisors Asset Management Inc. increased its stake in shares of Ambev SA by 19.2% in the first quarter. Advisors Asset Management Inc. now owns 113,783 shares of the company’s stock worth $655,000 after purchasing an additional 18,343 shares in the last quarter. DekaBank Deutsche Girozentrale increased its stake in shares of Ambev SA by 78.1% in the first quarter. DekaBank Deutsche Girozentrale now owns 57,000 shares of the company’s stock worth $330,000 after purchasing an additional 25,000 shares in the last quarter. US Bancorp DE increased its stake in shares of Ambev SA by 16.2% in the first quarter. US Bancorp DE now owns 423,319 shares of the company’s stock worth $2,439,000 after purchasing an additional 58,955 shares in the last quarter. Finally, Suntrust Banks Inc. increased its stake in shares of Ambev SA by 51.1% in the first quarter. Suntrust Banks Inc. now owns 190,361 shares of the company’s stock worth $1,095,000 after purchasing an additional 64,350 shares in the last quarter. 7.29% of the stock is owned by hedge funds and other institutional investors.

COPYRIGHT VIOLATION NOTICE: This piece was originally posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this piece can be read at https://www.thecerbatgem.com/2017/09/14/ambev-sa-abev-reaches-new-1-year-high-at-6-73.html.

Ambev SA Company Profile

Ambev SA, formerly Inbev Participacoes Societarias SA, is a Brazil-based company engaged in the brewing sector. The Company produces and sells beer, carbonated soft drinks (CSDs) and other non-alcoholic and non-carbonated (NANC) beverages across the Americas. The Company’s activities are divided into three segments: Latin America North, including sell of beer, CSD and NANC drinks in Brazil, as well as operations in Dominican Republic, Saint Vincent, Antigua, Dominica, Guatemala, El Salvador, Nicaragua and Cuba; Latin America South, distributing products in Argentina, Bolivia, Paraguay, Uruguay, Chile, Ecuador, Peru and Colombia, and Canada, represented by Labatt’s operations, which comprises sales in Canada.

Receive News & Stock Ratings for Ambev SA Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ambev SA and related stocks with our FREE daily email newsletter.